Weight loss drug ozempic tested in lung disease patients
NCT ID NCT05746039
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether semaglutide (Ozempic), a drug used for diabetes and obesity, is safe and tolerable for weight loss in people with advanced lung disease. Eight participants with conditions like COPD or pulmonary fibrosis will take weekly injections for 12 weeks. Researchers will monitor side effects, weight, and lung function to see if the drug can be used in this fragile group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide (Ozempic)
- What this could lead to
- If it works, this could show that semaglutide is a safe option for weight loss in people with advanced lung disease, potentially improving their quality of life.
- What could go wrong
- This is a very small pilot study with only 8 participants, so results may not apply to everyone. Side effects like nausea or vomiting could be worse in people with lung problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Pennsylvania Perelman School of Medicine
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Smart breathing machines at home: a new way to predict COPD crises?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Breathing easy? new X-Ray method may spot COPD decline early
- Coffee grounds probiotic could reshape gut health and fight inflammation